Private Equity
China-based Hangzhou Just Biotherapeutics, a biotherapeutics platform company, has closed $35 million in Series B+ financing. Hillhouse Capital led the round with participation from return backers Temasek, Lilly Asia Ventures, ARCH Venture Partners, Taikang and BOCGI Zheshang Capital.
1 min read · 06 June 2018
Menlo Park, California-based Portfolia Funds, a venture investing platform, has launched his sixth fund. No financial terms were disclosed. The Portfolia FemTech Fund will invest in emerging technologies, products and services focused on improving women's health and wellness.
3 min read · 06 June 2018
New York City-based pharmaceutical company Pfizer Inc is planning on investing $600 million in biotechnology and other emerging growth companies through Pfizer Ventures. About 25 percent of the funding will focus on neuroscience.
4 min read · 06 June 2018
Cambridge, Massachusetts-based Nference, a provider of an artificial intelligence software platform focused on biomedical knowledge, has closed $11 million in Series A financing. Matrix Partners led the round with participation from return backer Matrix Capital Management.
1 min read · 06 June 2018
3 min read · 05 June 2018
3 min read · 05 June 2018
Stride.VC has raised $10 million toward an $89.3 million maiden venture capital fund, according to a filing with the SEC.
1 min read · 05 June 2018
Woburn, Massachusetts-based Cytrellis Biosystems, a medical technology company that's developing new aesthetic devices, has secured $28.5 million in Series B funding. The investors included ARCH Venture Partners, the Merz Venture Initiative, Partner Fund Management and BioMatics Capital.</strong
1 min read · 05 June 2018
UK-based CMR Surgical Ltd, which is developing a next-generation surgical robot, has secured $100 million in Series B funding. The investors were Zhejiang Silk Road Fund, Escala Capital Investments, LGT, Cambridge Innovation Capital and Watrium.
1 min read · 05 June 2018
1 min read · 05 June 2018
